Veeva Systems – cloud-based software for the global life sciences industry

Veeva Systems’ healthcare professional and organization affiliations
data offering now spans most major markets and more than 19 million

Veeva Systems today announced the expansion of Veeva
customer reference and affiliations data to 12 Western
European countries and Canada. Veeva OpenData is now available in a
total of 32 countries, spanning more than 19 million practitioners and
representing more than 85% of global healthcare expenditures. With this
expansion, life sciences companies can rely on a single data provider in
all major markets for more targeted, compliant customer engagement. And
because data is priced by the record – with a defined-per country
maximum – companies now have fair pricing and a predictable cost of

“For too long, sales and marketing have been forced to purchase the same
data multiple times across teams and departments,” said Jim Cushman,
senior vice president and general manager of Veeva OpenData. “It’s our
aim to put an end to these exploitative practices. Companies purchase
Veeva OpenData just once and get comprehensive customer data, with
consistent quality, to use how and where they need it, without

Veeva OpenData provides rigorously verified and continuously updated
reference data for each country, drawing upon local market expertise,
while also delivering a standard, worldwide approach to data structure,
quality, customer service, and pricing. As a result, subscribers have
easy access to available healthcare professionals (HCPs), organizations
(HCOs), and affiliations data, in major life sciences markets worldwide.

With seamless integration to Veeva CRM, high-quality customer data is
readily accessible to commercial teams so they can better target
customers and tailor engagements – and do so far more efficiently.
Subscribers can engage in the right discussions, correctly track and
report aggregate spend, and ensure compliant activity with more accurate

“Reliable customer data has been notoriously difficult to obtain across
major countries, compromising compliance,” said Cushman. “Veeva OpenData
assures quality and completeness through stringent validation processes
in every one of the 32 countries Veeva serves. Taking this global
approach, Veeva OpenData can deliver a consistent standard for data
quality and customer service that is unmatched in the industry.”

Data change requests are a standard service included in subscriptions,
and most are resolved in less than one business day. Veeva also
introduced an industry first with its Veeva
OpenData Partner Program
, eliminating
the hassle of complicated three-party data access agreements. Freed to
fully leverage the customer data they purchase, companies can easily
share Veeva OpenData with any third party in an extensive partner

As of this month, Veeva OpenData is available in Australia, Austria,
Azerbaijan, Belarus, Belgium, Brazil, Canada, China, Denmark, Finland,
France, Georgia, Germany, Greece, Ireland, Italy, Japan, Kazakhstan,
Kyrgyzstan, Luxembourg, Moldova, The Netherlands, Norway, Portugal,
Russia, Spain, Sweden, Switzerland, Ukraine, United Kingdom, the United
States, and Uzbekistan. The company will continue to expand Veeva
OpenData to additional countries throughout 2016.

For a complete Veeva OpenData global coverage map, click here.

Additional Information
For more on Veeva OpenData, visit:
updated on the latest Veeva news on LinkedIn:
@veevasystems on Twitter:
Veeva on Facebook:

About Veeva Systems

Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 375 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices in Europe,
Asia, and Latin America. For more information, visit

Forward-looking Statements

This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations” in the company’s filing on Form
10-Q for the period ended October 31, 2015. This is available on the
company’s website at
under the Investors section and on the SEC’s website at
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to

Veeva Systems Inc.
Sue Glanville, +44 (0) 7715 817589
Bonthuys, +44 (0) 7746 546773

Veeva Systems - cloud-based software for the global life sciences industry